Switch to
More onapp

Panacea Biotec Ltd

PANACEABIO
Health CareBiotechnology
SmallcapWith a market cap of ₹798 cr, stock is ranked 1,150
Moderate RiskStock is 2.67x as volatile as Nifty
127.403.20 (-2.45%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareBiotechnology
SmallcapWith a market cap of ₹798 cr, stock is ranked 1,150
Moderate RiskStock is 2.67x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
0.74
PB RatioPB Ratio
0.94
Dividend YieldDiv. Yield
Sector PESector PE
34.15
Sector PBSector PB
4.18
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations.

Financial TrendFinancial statements 

20192020202120220.800.570.632.350.04-0.19-0.151.08
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Press Release 
Announced OnJan 17, 2023

Panacea Biotec Limited has informed the Exchange regarding a press release dated January 17, 2023, titled "Panacea Biotec donates 125,000 doses of Easyfive-TT (DTwP-HepB-Hib) a fully liquid Pentavalent vaccine to Ministry of Health, Republic of Cuba for use in the National Health System". | Download

Panacea Biotec Limited has informed the Exchange regarding a press release dated January 17, 2023, titled "Panacea Biotec donates 125,000 doses of Easyfive-TT (DTwP-HepB-Hib) a fully liquid Pentavalent vaccine to Ministry of Health, Republic of Cuba for use in the National Health System". | Download

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnJan 6, 2023

Panacea Biotec Limited has informed the Exchange about details of securities dematerialised during the quarter ended December 31, 2022 under SEBI (Depositories and Participants) Regulations, 2018 | Download

Panacea Biotec Limited has informed the Exchange about details of securities dematerialised during the quarter ended December 31, 2022 under SEBI (Depositories and Participants) Regulations, 2018 | Download

Cash Dividend 
Ex. DateSep 19, 2011

Final • Div/Share: ₹ 0.75

See all events